Valuation: OrganiGram

Market Cap 19Cr 13Cr 12Cr 11Cr 9.89Cr 1.27TCr 19Cr 127.98Cr 50Cr 624.71Cr 50Cr 48Cr 2.16TCr P/E 2026 *
10.2x
P/E 2027 * 33x
Enterprise Value 19Cr 13Cr 12Cr 11Cr 9.89Cr 1.27TCr 19Cr 127.98Cr 50Cr 624.71Cr 50Cr 48Cr 2.16TCr EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 13Cr
-1.03%-2.03%+36.88%+201.66% 22Cr
+2.15%-1.04%+5.56%+106.52% 13Cr
-6.02%-7.14%-2.50%-40.00% 7.92Cr
-0.25%-7.81%-14.82%-10.85% 7.99Cr
+1.94%+3.23%-42.83%-49.09% 5.28Cr
Average -1.18%-2.96%-3.54%+41.65% 11.31Cr
Weighted average by Cap. -1.22%-2.84%+9.25%+92.01%

Financials

2026 *2027 *
Net sales 34Cr 24Cr 21Cr 20Cr 18Cr 2.32TCr 34Cr 233.87Cr 91Cr 1.14TCr 91Cr 89Cr 3.95TCr 44Cr 31Cr 27Cr 26Cr 23Cr 3.01TCr 45Cr 303.6Cr 118.61Cr 1.48TCr 117.5Cr 114.97Cr 5.12TCr
Net income 1.89Cr 1.34Cr 1.18Cr 1.09Cr 1Cr 129.08Cr 1.92Cr 13Cr 5.08Cr 63Cr 5.03Cr 4.92Cr 219.42Cr 65.3L 46.37L 40.73L 37.87L 34.76L 45Cr 66.31L 4.5Cr 1.76Cr 22Cr 1.74Cr 1.7Cr 76Cr
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-